Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Rio Takeda shot a blistering 8-under 64 to win the LPGA’s Blue Bay tournament by six shots ahead of Minjee Lee of Australia.

Rio Takeda of Japan shot a 3-under 69 to hold a two-shot lead after three rounds of the LPGA’s Blue Bay tournament on China’s ...

SANYA, China — Rio Takeda shot a blistering 8-under 64 on Sunday to win the LPGA’s Blue Bay tournament by six shots ahead of ...

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

Japanese rookie Rio Takeda equalled the course record on her way to a dominant victory at the Blue Bay LPGA in China on ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, gastrointestinal (GI) and hematology, while pushing the Japanese company’s cell ...

M&T Bank Corp lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 10.0% in the 4th ...

Takeda is the second first-time winner this season, joining Yealimi Noh, who earned her first LPGA win at the Founders Cup.

Golf, often a game of patience and calculated risks, has a way of humbling even the greatest players. Just when it seems like ...

LPGA Tour rookie Rio Takeda carded an 8-under-par 64 on Sunday to cruise to a six-stroke victory at the Blue Bay LPGA on ...